Literature DB >> 12062995

Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

Valsa Madhava1, Christine Burgess, Ernest Drucker.   

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver disease in the world. The WHO estimates that 3% (170 million) of the world's population are chronically infected with HCV. Sub-Saharan Africa is of great interest because it is reported to have the highest HCV prevalence rate (5.3%), and a concurrent HIV epidemic. In our review of the published literature we found consistent evidence of high HCV prevalence in many countries of Africa. We estimate the overall prevalence of HCV in Sub-Saharan Africa is 3.0%. The central African region has the highest estimated prevalence of 6%, west Africa has an estimated prevalence of 2.4%, and southern and east Africa with the lowest estimated prevalence of 1.6%. Given low sexual transmission of HCV and infrequency of intravenous drug use in Sub-Saharan Africa, iatrogenic causes of HCV transmission need to be further evaluated.

Entities:  

Mesh:

Year:  2002        PMID: 12062995     DOI: 10.1016/s1473-3099(02)00264-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  99 in total

1.  Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.

Authors:  Ke-Qin Hu; Sue L Currie; Hui Shen; Ramsey C Cheung; Samuel B Ho; Edmund J Bini; John D McCracken; Tim Morgan; Norbert Bräu; Warren N Schmidt; Lennox Jeffers; Teresa L Wright
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

2.  Prevalence and risk factors for hepatitis C and human immunodeficiency virus coinfection among children in enugu, Nigeria.

Authors:  Jude Chijioke Eze; Ngozi S Ibeziako; Anthony N Ikefuna; Ikenna C Nwokoye; Nwachinaemere D Uleanya; Gideon C Ilechukwu
Journal:  Afr J Infect Dis       Date:  2014

3.  Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana.

Authors:  Premal Patel; Stephanie Davis; Michael Tolle; Vincent Mabikwa; Gabriel Anabwani
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

4.  Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria.

Authors:  Babatunde Olanrewaju Motayo; Adedayo Omotayo Faneye; Usen Asuquo Udo; Babatunde Adebiyi Olusola; Isreal Ezeani; Joseph Iruobe Ogiogwa
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

5.  Atlas of human diseases influenced by genetic variants with extreme allele frequency differences.

Authors:  Arvis Sulovari; Yolanda H Chen; James J Hudziak; Dawei Li
Journal:  Hum Genet       Date:  2016-10-03       Impact factor: 4.132

6.  Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.

Authors:  Abdirashid M Shire; Dalbir S Sandhu; Joseph K Kaiya; Abdul M Oseini; Ju Dong Yang; Roongruedee Chaiteerakij; Teresa A Mettler; Nasra H Giama; Rosebud O Roberts; Terry M Therneau; Gloria M Petersen; Keith L Knutson; Lewis R Roberts
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

7.  Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.

Authors:  A Tremeau-Bravard; I C Ogbukagu; C J Ticao; J J Abubakar
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

8.  Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda.

Authors:  S O M Namasopo; C Ndugwa; J K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

9.  Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.

Authors:  Cem Cengiz; Ulus S Akarca; Erdem Goker; Gul Yuce
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

10.  HIV and hepatitis C virus coinfection, Cameroon.

Authors:  Christian Laurent; Anke Bourgeois; Mireille Mpoudi; Christelle Butel; Eitel Mpoudi-Ngolé; Eric Delaporte
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.